Skip to content

PEG ratio at other companies

Amgen logo
AmgenAMGN
0.8×+0.3×
Biogen logo
BiogenBIIB
0.4×
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
0.5×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
0.2×
Johnson & Johnson logo
Johnson & JohnsonJNJ
0.2×
Exelixis logo
ExelixisEXEL
0.5×+0.4×

Other financials

Income statement

See full
Revenue$1.1B+19.1%
Operating income$336.6M+702%
Net income$293.1M+417%
EPS (diluted)$4.43+391%

Balance sheet

See full
Cash & equivalents$667.5M-64.1%
Total debt$5.4B-0.1%
Total equity$4.5B+8.6%
Total assets$11.9B+2.8%

Cash flow

See full
Operating cash flow$408.2M-5.0%
CapEx$19.7M+41.7%
Free cash flow$388.5M-6.6%

Valuation

See full
Market cap$14.11B+54.4%
Enterprise value$18.85B+47.7%
P/S3.2×+0.9×

Profitability

See full
Operating margin-11.9%-28.1pp
Net margin-8.9%-20.5pp
FCF margin28.6%-8.6pp

Returns & leverage

See full
Return on equity-9.1%-21.2pp
Debt / equity1.2×-0.1×
Current ratio-1.3×

Where this comes from

Calculated from Jazz Pharmaceuticals’s reported figures.

Based on the most recent quarter.

The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's peg ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Jazz Pharmaceuticals's PEG ratio?
Jazz Pharmaceuticals (JAZZ) reported PEG ratio of 0.3× in Q1 2025.
What does PEG ratio mean?
The P/E ratio adjusted for how fast earnings are growing.
How do you interpret PEG ratio?
Around 1.0 is often cited as fairly valued for the growth on offer; below 1.0 can flag a growth bargain. Highly sensitive to the growth input and meaningless when growth is zero or negative.
How does PEG ratio compare across companies?
A rough cross-company growth-adjusted screen; treat as directional given its sensitivity to the (trailing) growth basis.